Watertown, Mass., January 6, 2014 – Blend Therapeutics, Inc., a biopharmaceutical company discovering new classes of medicines to treat cancer, announced today that it has appointed pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback